Vincristine Shortage Spurs Pediatric Oncologists To Push Reform Ideas

A shortage of vincristine, one of the drugs essential to treating pediatric cancer, has the pediatric oncology community calling for both long-term and short-term drug shortage reforms. In the wake of the vincristine shortage , the Children’s Oncology Group (COG) is floating solutions to avert future drug shortages that could possibly occur in pediatric oncology. Peter Adamson, the chairman of COG, believes the long-term solution for such shortages lies in both Medicare reimbursement policies and economics. In the short-term, Adamson...